Detalhe da pesquisa
1.
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers.
J Transl Med
; 18(1): 94, 2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32085795
2.
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor ß1 Are Inversely Associated with Survival in Primary Breast Cancer.
Int J Mol Sci
; 21(1)2020 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31947762
3.
The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status.
Int J Mol Sci
; 20(5)2019 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30813617
4.
Prognostic relevance of RIP140 and ERß expression in unifocal versus multifocal breast cancers: a preliminary report.
Int J Mol Sci
; 20(2)2019 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30669416
5.
Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients.
Int J Mol Sci
; 18(6)2017 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632174
6.
Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.
Future Oncol
; 10(10): 1751-65, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25303055
7.
RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor.
Breast Cancer Res
; 15(1): R6, 2013 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23339407
8.
Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients.
Cells
; 11(7)2022 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406808
9.
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.
J Cancer Res Clin Oncol
; 147(9): 2535-2544, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085098
10.
Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer.
Cancers (Basel)
; 13(15)2021 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359656
11.
Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival.
Transl Oncol
; 11(5): 1090-1096, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30007204
12.
Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines.
Drugs R D
; 17(4): 569-583, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28879638
13.
Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer.
J Cancer Res Clin Oncol
; 143(7): 1107-1122, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28025696
14.
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer.
Oncotarget
; 8(62): 105356-105371, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29285256
15.
Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.
J Cancer Res Clin Oncol
; 147(9): 2545-2546, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269882
16.
Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
Breast Cancer Res
; 7(1): R60-70, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15642170
17.
Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer.
Transl Oncol
; 8(6): 509-16, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26692533
18.
Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells.
Endocrinology
; 144(3): 989-98, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12586776
19.
From genomic data analysis to drug development: a new generation of trials using molecular marker assessment in breast cance.
Chin Clin Oncol
; 3(2): 16, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25841412
20.
Molecular and protein markers for clinical decision making in breast cancer: today and tomorrow.
Cancer Treat Rev
; 40(3): 434-44, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24138841